Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low‐risk nonsymptomatic patients

21 Jan 2004

Abstract excerpt

OBJECTIVE: Our objective was to examine whether plasma fetal DNA can be used as a screening variable in those women who developed preeclampsia but without any clinical symptom at the time of blood draw. METHODS: Fetal DNA was extracted from 1.5-mL plasma samples, and the DYS14 gene was analyzed by real-time quantitative polymerase chain reaction. Plasma collected and frozen from six women were each paired with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14974111
DOI: 10.1002/pd.788

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low‐risk nonsymptomatic patientsPMID 14974111Read ↗

Total cell‐free DNA (β‐globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screeningSemantic proximity Read ↗

Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications.Semantic proximity Read ↗

Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomesSemantic proximity Read ↗

Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factorsSemantic proximity Read ↗

Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsiaSemantic proximity Read ↗

Increased Maternal Plasma Fetal DNA Concentrations in Women Who Eventually Develop Preeclampsia.Semantic proximity Read ↗

Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic reviewSemantic proximity Read ↗

Cell-Free Foetal DNA as a Useful Marker for Preeclampsia PredictionSemantic proximity Read ↗

A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.Semantic proximity Read ↗

Mitochondrial DNA copy number variation – A potential biomarker for early onset preeclampsiaSemantic proximity Read ↗

Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot StudySemantic proximity Read ↗

THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.